These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24255894)

  • 1. Vitamin E and diabetic nephropathy in mice model and humans.
    Farid N; Inbal D; Nakhoul N; Evgeny F; Miller-Lotan R; Levy AP; Rabea A
    World J Nephrol; 2013 Nov; 2(4):111-24. PubMed ID: 24255894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient selection and vitamin E treatment in diabetes mellitus.
    Goldenstein H; Levy NS; Lipener YT; Levy AP
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):319-26. PubMed ID: 23469912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
    Nakhoul FM; Miller-Lotan R; Awad H; Asleh R; Jad K; Nakhoul N; Asaf R; Abu-Saleh N; Levy AP
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F830-8. PubMed ID: 19176700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis--haptoglobin genotype and diabetic nephropathy.
    Nakhoul FM; Miller-Lotan R; Awaad H; Asleh R; Levy AP
    Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?
    Vardi M; Levy AP
    Curr Diab Rep; 2012 Jun; 12(3):274-9. PubMed ID: 22427005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
    Dalan R; Liuh Ling G
    Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haptoglobin genotype and its role in determining heme-iron mediated vascular disease.
    Goldenstein H; Levy NS; Levy AP
    Pharmacol Res; 2012 Jul; 66(1):1-6. PubMed ID: 22465143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo.
    Asleh R; Guetta J; Kalet-Litman S; Miller-Lotan R; Levy AP
    Circ Res; 2005 Mar; 96(4):435-41. PubMed ID: 15662028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.
    Asleh R; Blum S; Kalet-Litman S; Alshiek J; Miller-Lotan R; Asaf R; Rock W; Aviram M; Milman U; Shapira C; Abassi Z; Levy AP
    Diabetes; 2008 Oct; 57(10):2794-800. PubMed ID: 18599520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.
    Vardi M; Blum S; Levy AP
    Eur J Intern Med; 2012 Oct; 23(7):628-32. PubMed ID: 22939808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HAPTOGLOBIN POLYMORPHISM AS AN INDEPENDENT PREDICTOR OF DIABETIC NEPHROPATHY AND RETINOPATHY].
    Dahan I; Thauho N; Nakhoul F; Nakhoul N; Jabaly H; Farber E
    Harefuah; 2016 Jul; 155(7):439-442. PubMed ID: 28514126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between haptoglobin genotype and glycemic variability on diabetic macroangiopathy: a population-based cross-sectional study.
    Deng Z; Wang S; Lu J; Zhang R; Zhang L; Lu W; Zhu W; Bao Y; Zhou J; Hu C
    Endocrine; 2023 Nov; 82(2):311-318. PubMed ID: 37615814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
    Milman U; Blum S; Shapira C; Aronson D; Miller-Lotan R; Anbinder Y; Alshiek J; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):341-7. PubMed ID: 18032779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haptoglobin Genotype Is a Determinant of Hemoglobin Adducts and Vitamin E Content in HDL.
    Goldenstein H; Levy NS; Ward J; Costacou T; Levy AP
    J Diabetes Res; 2018; 2018():6125420. PubMed ID: 29888289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype.
    Blum S; Vardi M; Brown JB; Russell A; Milman U; Shapira C; Levy NS; Miller-Lotan R; Asleh R; Levy AP
    Pharmacogenomics; 2010 May; 11(5):675-84. PubMed ID: 20415560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation.
    Asleh R; Briasoulis A; Berinstein EM; Wiener JB; Palla M; Kushwaha SS; Levy AP
    Pharmgenomics Pers Med; 2018; 11():71-82. PubMed ID: 29731659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haptoglobin genotype determines myocardial infarct size in diabetic mice.
    Blum S; Asaf R; Guetta J; Miller-Lotan R; Asleh R; Kremer R; Levy NS; Berger FG; Aronson D; Fu X; Zhang R; Hazen SL; Levy AP
    J Am Coll Cardiol; 2007 Jan; 49(1):82-7. PubMed ID: 17207726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor lysosomal membrane integrity in proximal tubule cells of haptoglobin 2-2 genotype mice with diabetes mellitus.
    Asleh R; Nakhoul FM; Miller-Lotan R; Awad H; Farbstein D; Levy NS; Nakhoul N; Iancu TC; Manov I; Laue M; Traber MG; Lebold KM; Levy AP
    Free Radic Biol Med; 2012 Aug; 53(4):779-86. PubMed ID: 22749805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing the face of diabetic care with haptoglobin genotype selection and vitamin e.
    Levy NS; Levy AP
    Rambam Maimonides Med J; 2011 Apr; 2(2):e0047. PubMed ID: 23908805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus.
    Miller-Lotan R; Herskowitz Y; Kalet-Litman S; Nakhoul F; Aronson D; Zoabi R; Asaf R; Ben-Izhak O; Sabo E; Lim SK; Baumann H; Berger FG; Levy AP
    Diabetes Metab Res Rev; 2005; 21(4):332-7. PubMed ID: 15852445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.